Company news
Cann Group Ltd. (ASX:CAN) news
Cann Group Ltd. news releases on 6ix. Latest, Jan 25, 2022: Cann granted GMP licence & other regulatory updates
Press releases — page 3
Cann granted GMP licence & other regulatory updates
January 24, 2022
Results of Share Purchase Plan offer
October 20, 2021
Appendix 4E & Audited Financial Statements for FY21
August 22, 2021
Cann proceeds with Schedule 3 CBD registration program
August 12, 2021
Investor presentation regarding capital raising
July 25, 2021
Update on recovery of missing funds
July 8, 2021
Cann provides further revenue update
May 28, 2021
Appendix 4C - quarterly
April 29, 2021
Cann commences proceeding in Hong Kong to recover funds
March 29, 2021
Cann and Emyria partner to register CBD product
March 28, 2021
Cann Group - Half yearly investor presentation
February 21, 2021
Federal Court orders granted
February 16, 2021
Cann investor update
February 14, 2021
Cyber security incident
February 7, 2021
Correction of trading halt request
February 5, 2021
Cann receives $3.2M R&D tax refund
January 7, 2021
Strategic investment and European supply order
January 5, 2021
First shipment to UK supply partner
December 21, 2020
Execution of bank facility documentation
December 14, 2020
Mildura facility licences granted
November 25, 2020
Debt facility update
November 24, 2020
Chairmans & CEOs Addresses to Shareholders
November 23, 2020
Approval for bank debt facility
November 22, 2020
Aurora Cannabis sells ownership position in Cann Group
October 11, 2020
CAN - FY20 Results Presentation
August 27, 2020
Appendix 4E & Annual Report to shareholders
August 26, 2020
Details of completed Share Purchase Plan (SPP)
August 18, 2020
Close of SPP Offer
August 12, 2020
Results of placement
July 23, 2020
Share Purchase Plan - Cleansing Statement
July 21, 2020
Investor presentation for capital raising
July 16, 2020
Victorian Government Regional Jobs Fund Grant
July 3, 2020
S&P DJI Announces June 2020 Quarterly Rebalance
June 11, 2020
Execution of export supply agreements
May 25, 2020
Presentation at NWR Virtual Health Conference
May 3, 2020
Correction to Appendix 4C
April 28, 2020
Cann executes supply agreement with Pure Cann NZ
April 20, 2020
Business update
April 1, 2020
Appendix 4D
February 25, 2020
Secures Institutional Funding Support for Working Capital
February 6, 2020
Correction of typographical error - Appendix 4C
February 2, 2020
Market update - presentation
January 28, 2020
Commercial-scale GMP medicinal cannabis resin extraction
January 6, 2020
CAN and IDT announce commercial manufacture
December 18, 2019
Annual General Meeting Presentation
November 29, 2019
Chairmans and CEOs Address to Shareholders
November 28, 2019
Staged approach to Mildura facility and bank facility update
November 21, 2019
Cann executes national distribution agreement with Symbion
November 6, 2019
Full year results presentation
August 27, 2019
2019 Annual Report and Appendix 4E
August 26, 2019